BSX Q4 2022 Earnings — Boston Scientific Corporation Revenue & Financial Results | Market Cap Arena

BSXBoston Scientific Corporation

$105B

Q4 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$3.2B+3.7% YoY

Gross Profit

$2.0B60.3% margin

Operating Income

$449M13.8% margin

Net Income

$140M4.3% margin

EPS (Diluted)

$0.09

QoQ Revenue Growth

+2.3%

Cash Flow

Operating Cash Flow

$807M

Free Cash Flow

$607M

Stock-Based Comp.

$55M

Balance Sheet

Total Assets

$32.5B

Total Liabilities

$14.9B

Stockholders' Equity

$17.6B

Cash & Equivalents

$928M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3.2B	$3.1B	+3.7%
Gross Profit	$2.0B	$1.9B	+0.7%
Operating Income	$449M	$457M	-1.8%
Net Income	$140M	$94M	+48.9%

Revenue Segments

Cardiovascular

$2.1B61%

MedSurg

$1.4B39%

Geographic Segments

UNITED STATES

$2.0B60%

Non-US

$1.3B40%